ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Graviola Fruit Extract

Also known as: Graviola, Soursop, Guanabana, Annona muricata

Overview

Graviola, known scientifically as *Annona muricata*, is a tropical plant indigenous to the Americas and the Caribbean. This plant is particularly renowned for its fruit and leaves, which have been employed in traditional medicine to treat various ailments, including fevers and rheumatism. The plant contains bioactive compounds such as acetogenins, which are believed to exhibit notable anticancer properties. Despite its traditional uses, research on Graviola is still emerging, predominantly focusing on preclinical studies, with limited clinical evidence available. Most studies indicate potential benefits, especially in cancer cell cytotoxicity; however, these findings require more rigor in clinical trials to establish definitive conclusions on efficacy and safety.

Benefits

Graviola extracts demonstrate cytotoxic effects on cancer cells, primarily attributed to their ability to induce apoptosis. Notable studies have shown promising results in inhibiting cancer cells, specifically HeLa cells, although clinical evidence remains limited and inconclusive. Secondary potential benefits, including hepatoprotective and anti-ulcerative effects, have also been observed in preclinical research. However, the significance of these benefits is unclear, as well-controlled clinical trials validating these effects in specific populations are lacking. Overall, while Graviola shows potential, the strength of evidence is weak and calls for further investigation.

How it works

The mechanism of action for Graviola primarily involves its bioactive compounds, particularly acetogenins, which are thought to inhibit mitochondrial ATP production within cancer cells. This inhibition may lead to a disruption in energy metabolism, effectively triggering cell death through apoptosis pathways. Additionally, Graviola's potential interaction with cellular membranes and a specific target, NADH oxidase, in cancer cells further contributes to its anticancer effects. Current knowledge regarding absorption and bioavailability remains limited, indicating a need for more in-depth pharmacokinetic studies.

Side effects

Graviola is generally regarded as safe when used traditionally, though there are concerns regarding potential neurotoxic effects associated with high doses. Documented side effects are sparse due to a lack of extensive clinical data, but caution is advised, especially in individuals with neurological conditions or those taking medications that influence liver function and blood sugar levels. Pregnant and breastfeeding women are also advised against using Graviola due to insufficient safety data. While common side effects are not well-established, potential for neurotoxic side effects may develop with excessive consumption, warranting careful observation of dosage and patient history during use.

Dosage

No universally established minimum effective dose for Graviola exists, but clinical trials have explored dosages ranging from 100 mg to 300 mg per day. However, the maximum safe dosage remains undetermined, highlighting a gap in current research. While no specific timing or administration recommendations are provided, Graviola is typically available in capsule or extract forms. Absorption characteristics require further exploration, as available literature does not provide comprehensive data on bioavailability or recommendations for usage coupled with dietary factors. It is important to establish patient-specific requirements and closely monitor dosage to mitigate any potential risks.

FAQs

Can Graviola be used as a substitute for cancer treatment?

No, Graviola should not replace conventional cancer treatments; consult a healthcare provider for comprehensive treatment options.

Are there safety concerns with Graviola consumption?

High doses of Graviola may pose neurotoxic risks; moderation and professional guidance are advised.

What is the best time to take Graviola?

There are no specific timing recommendations for Graviola; follow product guidelines and physician advice.

What results can I expect from using Graviola?

Due to limited clinical evidence, expected results are uncertain; effects may vary significantly among individuals.

Is it true that Graviola is a proven cancer remedy?

That misconception is widespread; while Graviola shows potential in lab studies, clinical efficacy is not yet proven.

Research Sources

  • https://onlinelibrary.wiley.com/doi/10.1111/jphp.13182 – This systematic review evaluates the safety and efficacy of *Annona muricata* leaf extract, indicating potential hepatoprotective and chemopreventive effects, while emphasizing the need for more human studies to confirm findings.
  • https://pubmed.ncbi.nlm.nih.gov/23889049/ – An experimental study demonstrating significant inhibition of HeLa cancer cells by Graviola extracts, suggesting potential anticancer activity, though results require further validation in clinical settings.
  • https://mjpharm.org/effect-of-annona-muricata-soursop-on-patients-with-cancer-a-systematic-review/ – This review assesses *Annona muricata* extracts’ effects on cancer, revealing cytotoxic properties, but also outlines significant methodological limitations across existing studies, necessitating cautious interpretations of efficacy.